PAA 7.89% 20.5¢ pharmaust limited

Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow), page-30

  1. 12,267 Posts.
    lightbulb Created with Sketch. 6274
    Market not held back awaiting Tablets but Trialing is dependent on them before we commence .

    PAA are next cab off the rank with Healey
    PAA Have circa $18m
    PAA have access now to 70 Trial Sites

    PAA require Tablets to proceed NZT

    Yes DXB is a great example of Value Build and Licensing ,,,
    Last edited by NZ Trader: 31/07/24
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.